Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs

[1]  Xinran Dong,et al.  Optimized trio genome sequencing (OTGS) as a first-tier genetic test in critically ill infants: practice in China , 2020, Human Genetics.

[2]  Y. Chien,et al.  Critical Trio Exome Benefits In-Time Decision-Making for Pediatric Patients With Severe Illnesses. , 2019, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[3]  Kiely N. James,et al.  A Randomized, Controlled Trial of the Analytic and Diagnostic Performance of Singleton and Trio, Rapid Genome and Exome Sequencing in Ill Infants. , 2019, American journal of human genetics.

[4]  Y. Chien,et al.  Primary coenzyme Q10 deficiency-7: expanded phenotypic spectrum and a founder mutation in southern Chinese , 2019, npj Genomic Medicine.

[5]  S. Kingsmore,et al.  Rapid Whole Genome Sequencing Has Clinical Utility in Children in the PICU. , 2019, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[6]  M. Farrer,et al.  RAPIDOMICS: rapid genome-wide sequencing in a neonatal intensive care unit—successes and challenges , 2019, European Journal of Pediatrics.

[7]  M. Relling,et al.  Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update , 2019, Clinical pharmacology and therapeutics.

[8]  John Reynders,et al.  Diagnosis of genetic diseases in seriously ill children by rapid whole-genome sequencing and automated phenotyping and interpretation , 2019, Science Translational Medicine.

[9]  Sri V. V. Deevi,et al.  Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children , 2019, Intensive Care Medicine.

[10]  B. Chung,et al.  Healthcare burden of rare diseases in Hong Kong – adopting ORPHAcodes in ICD-10 based healthcare administrative datasets , 2018, Orphanet Journal of Rare Diseases.

[11]  S. Kingsmore,et al.  Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases , 2018, npj Genomic Medicine.

[12]  S. Kingsmore,et al.  Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization , 2018, npj Genomic Medicine.

[13]  V. Speare,et al.  Exome sequencing in neonates: diagnostic rates, characteristics, and time to diagnosis , 2018, Genetics in Medicine.

[14]  M. Bitner-Glindzicz,et al.  Rapid Paediatric Sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children , 2018, Journal of Medical Genetics.

[15]  Melbourne Genomics Health Alliance,et al.  Meeting the challenges of implementing rapid genomic testing in acute pediatric care , 2018, Genetics in Medicine.

[16]  Laurie D. Smith,et al.  The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants , 2017, npj Genomic Medicine.

[17]  David R. FitzPatrick,et al.  Paediatric genomics: diagnosing rare disease in children , 2018, Nature Reviews Genetics.

[18]  B. Chung,et al.  Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism , 2017, Molecular Autism.

[19]  Fan Xia,et al.  Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management , 2017, JAMA pediatrics.

[20]  J. Rivière,et al.  Reducing diagnostic turnaround times of exome sequencing for families requiring timely diagnoses. , 2017, European journal of medical genetics.

[21]  Birgit Sikkema-Raddatz,et al.  Rapid Targeted Genomics in Critically Ill Newborns , 2017, Pediatrics.

[22]  Clara Gaff,et al.  Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions , 2017, JAMA pediatrics.

[23]  J. Bernstein,et al.  Angioedema in the emergency department: a practical guide to differential diagnosis and management , 2017, International Journal of Emergency Medicine.

[24]  Clara Gaff,et al.  Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement , 2017, Genetics in Medicine.

[25]  N. Spinner,et al.  Early life predictive markers of liver disease outcome in an International, Multicentre Cohort of children with Alagille syndrome , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[26]  Laurie D. Smith,et al.  Whole-Exome Sequencing and Whole-Genome Sequencing in Critically Ill Neonates Suspected to Have Single-Gene Disorders. , 2016, Cold Spring Harbor perspectives in medicine.

[27]  Laurie D. Smith,et al.  Rapid whole genome sequencing and precision neonatology. , 2015, Seminars in perinatology.

[28]  Laurie D. Smith,et al.  Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. , 2015, The Lancet. Respiratory medicine.

[29]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[30]  Xuan Yuan,et al.  Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders , 2014, Science Translational Medicine.

[31]  David T. Miller,et al.  Chromosomal microarray impacts clinical management , 2014, Clinical genetics.

[32]  Peter Saffrey,et al.  Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units , 2012, Science Translational Medicine.

[33]  S. Uchida,et al.  [Pseudohypoaldosteronism type II]. , 2011, Nihon Jinzo Gakkai shi.

[34]  C1 esterase inhibitor (human). , 2010, P & T : a peer-reviewed journal for formulary management.

[35]  M. Avigan,et al.  Finding, evaluating, and managing drug‐related risks: approaches taken by the US Food and Drug Administration (FDA) , 2009, Dermatologic therapy.

[36]  Bernadette Modell,et al.  March of Dimes: global report on birth defects, the hidden toll of dying and disabled children. , 2005 .

[37]  W. Mcalister,et al.  Gastrointestinal and renal abnormalities in cardio-facio-cutaneous syndrome , 2005, Pediatric Radiology.

[38]  H. Kong.  The Government of the Hong Kong Special Administrative Region , 2002 .